| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Taysha Gene Therapies, Inc. | President and Head of R&D, Director | Common Stock | 898K | $1.46M | $1.63 | Jan 2, 2024 | Direct |
| Taysha Gene Therapies, Inc. | President and Head of R&D, Director | Employee Stock Option (right to buy) | 864K | Jan 2, 2024 | Direct | ||
| Solid Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 34.4K | Jun 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| TSHA | Taysha Gene Therapies, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | President and Head of R&D, Director |
| TSHA | Taysha Gene Therapies, Inc. | Dec 14, 2023 | 1 | $0 | 4 | Dec 18, 2023 | President and Head of R&D, Director |
| SLDB | Solid Biosciences Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| TSHA | Taysha Gene Therapies, Inc. | May 16, 2023 | 1 | $3.4K | 4 | May 18, 2023 | President and Head of R&D, Director |
| TSHA | Taysha Gene Therapies, Inc. | Dec 30, 2022 | 1 | $0 | 4 | Jan 4, 2023 | President and Head of R&D, Director |
| SLDB | Solid Biosciences Inc. | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director |
| TSHA | Taysha Gene Therapies, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
| SLDB | Solid Biosciences Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
| TSHA | Taysha Gene Therapies, Inc. | Feb 2, 2022 | 1 | $80.1K | 4 | Feb 3, 2022 | Director |
| TSHA | Taysha Gene Therapies, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| SLDB | Solid Biosciences Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |